Balance Sheet

Assets

+48%

+114%

10Y

Currency: JPY

	Mar-2002	Mar-2003	Mar-2004	Mar-2005	Mar-2006	Mar-2007	Mar-2008	Mar-2009	Mar-2010	Mar-2011	Mar-2012	Mar-2013	Mar-2014	Mar-2015	Mar-2016	Mar-2017	Mar-2018	Mar-2019	Mar-2020	Mar-2021	Mar-2022	Mar-2023	Mar-2024	Mar-2025
Assets
Cash & Cash Equivalents	6 589	5 812	7 342	6 815	6 657	7 108	9 809	6 151	13 373	14 106	15 381	19 868	23 028	25 733	23 073	23 924	30 532	37 856	45 307	52 964	72 791	79 951	89 210	77 161
Cash Equivalents	6 589	5 812	7 342	6 815	6 657	7 108	9 809	6 151	13 373	14 106	15 381	19 868	23 028	25 733	23 073	23 924	30 532	37 856	45 307	52 964	72 791	79 951	89 210	77 161
Short-Term Investments	302	318	13	1 610	0	0	21	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Receivables	19 016	17 282	16 003	20 139	22 559	25 903	27 450	27 689	27 989	29 722	31 804	31 840	32 810	38 798	48 824	46 096	49 964	44 364	50 416	47 865	51 682	60 656	69 115	69 880
Accounts Receivables	19 016	17 282	16 003	20 139	22 559	25 903	27 450	27 689	27 989	29 722	31 804	31 840	32 810	38 798	48 824	46 096	49 964	44 364	50 416	47 865	51 682	60 656	69 115	69 415
Other Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	465
Inventory	8 829	9 230	9 070	10 761	12 160	11 926	12 475	14 345	15 284	16 336	18 005	19 456	21 381	22 568	23 035	23 609	26 228	30 260	31 223	27 925	33 527	41 062	46 657	61 580
Other Current Assets	2 530	2 412	2 310	3 536	3 242	3 304	3 657	4 177	3 834	4 931	6 090	6 303	5 762	6 593	6 820	7 319	3 326	3 922	3 760	4 317	6 306	8 577	9 777	9 258
Total Current Assets	37 266	35 054	34 738	42 861	44 618	48 241	53 412	52 362	60 480	65 100	71 280	77 467	82 981	93 692	101 752	100 948	110 050	116 402	130 706	133 071	164 306	190 246	214 759	217 879
PP&E Net	24 997	27 630	25 355	24 821	29 788	34 455	33 908	35 646	35 267	39 426	42 628	44 758	48 563	50 370	48 040	45 834	47 193	47 421	48 539	49 790	62 839	66 182	68 607	90 451
PP&E Gross	24 997	27 630	25 355	24 821	29 788	34 455	33 908	35 646	35 267	39 426	42 628	44 758	48 563	50 370	48 040	45 834	47 193	47 421	48 539	49 790	62 839	66 182	68 607	90 451
Accumulated Depreciation	20 725	22 735	25 600	27 414	30 050	38 305	40 870	43 088	45 874	47 862	51 472	56 273	61 104	65 676	68 180	70 588	74 496	77 643	84 622	86 877	99 274	106 462	113 801	141 340
Intangible Assets	586	410	984	2 899	4 384	4 314	3 631	1 301	1 449	1 342	1 315	1 242	2 253	3 050	2 372	1 928	2 605	2 482	2 685	4 590	6 587	6 997	6 932	8 575
Goodwill	5 970	2 362	2 012	7 929	8 898	10 927	9 655	2 423	1 353	1 150	958	766	575	1 326	1 130	735	1 503	1 083	2 445	3 304	2 954	2 564	2 285	47 494
Note Receivable	0	0	0	0	0	0	0	0	0	0	0	3 392	2 075	1 869	0	3 203	2 799	2 837	3 097	3 361	5 420	5 687	5 990	6 751
Long-Term Investments	13 486	11 193	16 977	17 931	24 198	26 407	18 347	16 691	18 448	15 345	14 945	18 537	22 724	24 325	21 405	27 502	32 328	28 530	23 880	26 226	28 132	33 637	44 337	46 427
Other Long-Term Assets	1 338	1 368	1 161	905	929	969	1 224	3 654	3 766	4 104	4 882	4 481	3 078	2 877	2 304	1 393	1 688	2 198	4 292	5 807	4 638	4 364	3 265	4 298
Other Assets	5 970	2 362	2 012	7 929	8 898	10 927	9 655	2 423	1 353	1 150	958	766	575	1 326	1 130	735	1 503	1 083	2 445	3 304	2 954	2 564	2 285	47 494
Total Assets	83 643 N/A	78 017 -7%	81 227 +4%	97 346 +20%	112 815 +16%	125 313 +11%	120 177 -4%	112 077 -7%	120 763 +8%	126 467 +5%	136 008 +8%	150 643 +11%	162 249 +8%	177 509 +9%	179 573 +1%	181 543 +1%	198 166 +9%	200 953 +1%	215 644 +7%	226 149 +5%	274 876 +22%	309 677 +13%	346 175 +12%	421 875 +22%
Liabilities
Accounts Payable	4 912	5 401	5 024	5 576	6 700	6 561	8 015	8 383	8 685	9 121	10 525	10 151	11 753	10 201	12 355	12 151	15 072	14 068	14 243	11 330	16 269	18 718	21 123	22 056
Accrued Liabilities	7 853	7 613	8 707	9 880	10 554	12 609	14 380	13 296	14 625	17 117	18 214	21 669	24 922	29 555	29 725	26 316	27 544	28 871	29 485	26 398	19 483	25 544	27 292	25 352
Short-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	7 197	3 807	3 038	3 516	3 378	734	534	1 849	694	1 373	4 165
Current Portion of Long-Term Debt	7 313	3 708	1 613	3 305	4 432	8 096	3 997	4 252	3 526	3 199	5 103	5 611	10 836	3 810	3 361	3 041	3 470	3 301	4 519	5 152	9 647	7 613	8 092	10 126
Other Current Liabilities	7 854	8 132	7 282	10 623	10 669	10 054	11 178	9 786	10 347	12 303	11 093	12 123	9 132	6 844	10 109	8 876	11 730	11 142	13 136	13 057	24 240	27 593	29 207	32 909
Total Current Liabilities	27 934	24 855	22 626	29 384	32 355	37 320	37 570	35 717	37 183	41 740	44 935	49 554	56 643	57 607	59 357	53 422	61 332	60 760	62 117	56 471	71 488	80 162	87 087	94 608
Long-Term Debt	8 300	10 837	9 297	13 957	10 052	7 960	6 603	4 679	4 621	2 716	3 335	1 578	1 666	1 128	1 035	1 765	1 768	1 483	5 469	5 971	13 529	8 700	6 688	50 374
Deferred Income Tax	2 288	1 040	3 166	3 342	5 773	6 975	4 342	2 735	3 309	2 317	1 917	3 264	2 138	3 260	2 300	2 492	987	255	716	998	1 537	1 173	1 597	2 081
Minority Interest	9	11	10	9	71	92	47	46	55	241	273	320	379	425	462	434	755	917	749	704	5 594	5 508	710	11 345
Other Liabilities	2 462	2 700	2 452	2 559	1 846	3 103	2 243	1 832	1 978	1 782	2 193	2 476	3 175	4 998	5 610	5 428	5 639	6 266	7 310	6 097	4 328	4 564	3 767	3 372
Total Liabilities	40 992 N/A	39 443 -4%	37 551 -5%	49 251 +31%	50 097 +2%	55 450 +11%	50 805 -8%	45 009 -11%	47 146 +5%	48 796 +3%	52 653 +8%	57 192 +9%	64 001 +12%	67 418 +5%	68 764 +2%	63 541 -8%	70 481 +11%	69 681 -1%	76 361 +10%	70 241 -8%	96 476 +37%	100 107 +4%	99 849 0%	161 780 +62%
Equity
Common Stock	3 281	3 284	3 284	3 288	5 409	5 743	5 860	6 398	6 398	6 398	6 405	6 408	6 411	6 411	6 411	6 415	6 415	6 446	6 504	6 504	6 504	6 504	6 504	6 504
Retained Earnings	33 093	30 935	33 860	38 519	43 959	49 374	55 645	55 288	61 415	68 104	74 393	80 250	87 073	92 883	99 243	106 862	113 256	120 487	132 367	145 893	162 686	184 387	209 781	228 824
Additional Paid In Capital	2 396	2 400	2 399	2 408	4 530	4 862	4 980	5 517	5 517	5 517	5 524	5 527	5 738	5 738	5 738	5 737	5 737	5 603	5 661	5 661	5 791	5 292	4 516	0
Unrealized Security Profit/Loss	4 129	3 504	6 023	6 147	9 599	10 106	4 878	3 903	4 698	2 870	2 432	3 776	5 033	6 646	0	5 862	8 220	6 279	4 144	6 717	5 992	7 951	11 276	9 466
Treasury Stock	255	273	276	212	135	173	203	234	261	268	270	273	5 785	5 451	0	4 938	4 935	4 935	4 935	4 936	4 936	4 938	4 939	9 939
Other Equity	7	1 278	1 614	2 058	644	49	1 791	3 803	4 153	4 953	5 130	2 237	222	3 864	814	1 936	1 008	2 608	4 458	3 931	2 363	10 374	19 188	25 240
Total Equity	42 651 N/A	38 574 -10%	43 676 +13%	48 092 +10%	62 718 +30%	69 863 +11%	69 369 -1%	67 069 -3%	73 614 +10%	77 668 +6%	83 354 +7%	93 451 +12%	98 248 +5%	110 091 +12%	110 809 +1%	118 002 +6%	127 685 +8%	131 272 +3%	139 283 +6%	155 908 +12%	178 400 +14%	209 570 +17%	246 326 +18%	260 095 +6%
Total Liabilities & Equity	83 643 N/A	78 017 -7%	81 227 +4%	97 343 +20%	112 815 +16%	125 313 +11%	120 174 -4%	112 078 -7%	120 760 +8%	126 464 +5%	136 007 +8%	150 643 +11%	162 249 +8%	177 509 +9%	179 573 +1%	181 543 +1%	198 166 +9%	200 953 +1%	215 644 +7%	226 149 +5%	274 876 +22%	309 677 +13%	346 175 +12%	421 875 +22%
Shares Outstanding
Common Shares Outstanding	107	107	107	107	114	114	116	118	118	118	118	118	113	114	114	228	228	228	228	228	228	228	228	226

Income Statement Balance Sheet Cash Flow Statement

Rohto Pharmaceutical Co Ltd
TSE:4527

Balance Sheet

Balance Sheet Decomposition
Rohto Pharmaceutical Co Ltd

Balance Sheet
Rohto Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Rohto Pharmaceutical Co Ltd TSE:4527

Balance Sheet

Balance Sheet Decomposition Rohto Pharmaceutical Co Ltd

Balance Sheet Rohto Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Rohto Pharmaceutical Co Ltd
TSE:4527

Balance Sheet Decomposition
Rohto Pharmaceutical Co Ltd

Balance Sheet
Rohto Pharmaceutical Co Ltd